SGRYNasdaqServices-General Medical & Surgical Hospitals, NECFiscal year ends December 31

Surgery Partners, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026

$14.71+0.10 (+0.68%)

Close on Oct 19, 2026

Market cap: $1.90B
P/E (TTM): –
Dividend yield: –

Surgery Partners, Inc. income statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31
Revenue	3,309	3,114	2,743	2,539	2,225	1,860	1,831	1,772	1,145	960	403	285
Cost of Revenue	–	–	–	–	–	–	1,408	1,361	821	669	254	170
Gross Profit	–	–	–	–	–	–	424	410	324	291	149	115
General & Administrative	118	139	121	102	104	97	89	94	60	56	31	26
Operating Expenses	2,919	2,766	2,415	2,194	1,923	1,677	1,596	1,694	949	815	352	226
Total Costs & Expenses	–	–	–	–	–	–	1,596	1,694	–	–	–	–
Operating Income	390	349	328	345	302	183	236	78	196	145	51	58
Income from Equity Investments	23	20	14	13	11	11	10	8.90	4.76	3.78	1.26	0
Other Non-Operating Income	–	–	8.60	1.50	-0.20	–	–	–	–	–	–	–
Asset Impairment Charges	0	0	0	0	0	34	7.90	74	0	0	0	0.58
Gain (Loss) on Sale of Assets	–	–	–	–	–	–	–	-32	-2.36	2.10	-1.80	-2.48
Legal Settlements	-7.30	0.80	-11	29	0	-1.20	-0.20	-46	14	0	0	–
Income Tax Expense	18	135	-0.30	23	11	-20	9.50	26	7.10	-149	16	7.57
Net Income incl. Noncontrolling Interests	99	13	135	87	71	1.30	45	-96	85	73	-27	18
Minority Interest in Earnings	177	181	147	142	142	117	120	110	76	71	39	27
Net Income	-78	-168	-12	-55	-71	-116	-75	-206	9.45	1.43	-66	-9.06
Net Income to Common	–	–	-12	-55	-81	-156	-111	-238	–	–	–	–
EPS (Basic)(per share)	-0.61	-1.33	-0.09	-0.59	-1.12	-3.19	-2.29	-4.96	0.20	0.04	-2.04	-0.28
EPS (Diluted)(per share)	-0.61	-1.33	-0.09	-0.59	-1.12	-3.19	-2.29	-4.96	0.20	0.04	-2.04	-0.28
Shares Outstanding (Basic, Weighted)(shares)	127	126	126	92	72	49	48	48	48	36	32	32
Shares Outstanding (Diluted, Weighted)(shares)	127	126	126	92	72	49	48	48	48	37	32	32
EBITDA	566	501	446	460	401	278	312	145	236	179	66	70

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: –
Operating margin: 11.4%
Net margin: -2.6%
Return on equity, FY2025: -4.4%

Financial strength

Current ratio: 1.95
Debt to equity: 2.25
Debt to assets: 46.6%
Cash to current liabilities: 37.5%

Valuation

P/E ratio: –
Price to sales: 0.56
Price to book: 1.13
Dividend yield: –